Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
We now rank 3rd in pharmaceutical production by volume and 14th by value
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
he company will focus on production of any pharmaceutical and biotechnological products
Subscribe To Our Newsletter & Stay Updated
